All‐cause mortality · Patients undergoing any type of surgery under general anaesthesia receiving ACEIs or ARBs perioperatively
It is very uncertain whether ACEIs or ARBs changes all‐cause mortality compared with placebo (very low certainty).
1 finding from 1 review
All‐cause mortality · people with haematological disorders undergoing intensive chemotherapy or stem cell transplantation
1 finding from 1 review
no estimate extracted
4 participants
GRADE not reported
All‐cause mortality · People with chronic bone marrow failure
It is very uncertain whether thrombopoietin mimetic changes all‐cause mortality compared with placebo (very low certainty).
1 finding from 1 review
All‐cause mortality · participants with high risk of sudden cardiac death (primary prevention)
Amiodarone showed no clear difference in all‐cause mortality compared with placebo or no treatment (low certainty).
1 finding from 1 review
All‐cause mortality · participants with high risk of sudden cardiac death (secondary prevention)
It is very uncertain whether amiodarone changes all‐cause mortality compared with placebo or no treatment (very low certainty).
1 finding from 1 review
All‐cause mortality · patients with acute myocardial infarction
Lidocaine showed no clear difference in all‐cause mortality compared with placebo or no intervention (low certainty).
1 finding from 1 review
All‐cause mortality · people with traumatic head injuries
It is very uncertain whether antiepileptic drugs changes all‐cause mortality compared with placebo or standard care (very low certainty).
1 finding from 1 review
All‐cause mortality · people with traumatic head injuries
Neuroprotective agent showed no clear difference in all‐cause mortality compared with placebo (high certainty).
1 finding from 1 review
All‐cause mortality · healthy participants or recruited among the general population; individuals diagnosed with a specific disease in a stable phase or with…
Vitamin D may leads to lower all‐cause mortality compared with placebo or no intervention (low certainty).
1 finding from 1 review
All‐cause mortality · patients with paroxysmal nocturnal hemoglobinuria
1 finding from 1 review
All‐cause mortality · solid organ transplant recipients with CMV viraemia
1 finding from 1 review
All‐cause mortality · patients at high risk of severe respiratory syncytial virus infection
Palivizumab showed no clear difference in all‐cause mortality compared with placebo (moderate certainty).
1 finding from 1 review
All‐cause mortality · participants with improving outcomes during and after noncardiac vascular surgery.
Perioperative statins showed no clear difference in all‐cause mortality compared with placebo or no treatment (low certainty).
1 finding from 1 review
All‐cause mortality · patients with primary biliary cirrhosis.
It is very uncertain whether ursodeoxycholic acid changes all‐cause mortality compared with placebo or no intervention (very low certainty).
1 finding from 1 review
All‐cause mortality · children under 12 years of age
1 finding from 1 review
All‐cause mortality · patients with primary biliary cirrhosis.
It is very uncertain whether bisphosphonates changes all‐cause mortality compared with placebo or no intervention (very low certainty).
1 finding from 1 review
All‐cause mortality · women with primary biliary cirrhosis.
It is very uncertain whether hormone replacement changes all‐cause mortality compared with placebo or no intervention (very low certainty).
1 finding from 1 review
All‐cause mortalityb
It is very uncertain whether booster changes all‐cause mortalityb compared with placebo/no booster (very low certainty).
1 finding from 1 review
All‐cause mortalityf
mRNA‐1273 – ModernaTX showed no clear difference in all‐cause mortalityf compared with placebo (low certainty).
1 finding from 1 review
All‐cause mortalityh
It is very uncertain whether CVnCoV – CureVac AG changes all‐cause mortalityh compared with placebo (very low certainty).
1 finding from 1 review